At 13000 volunteers, Covaxin Phase-3 clinical trials in India cross half-way mark,

The Phase 3 human clinical trials of India’s first indigenous Covid vaccine Covaxin began in mid-November, targeted to be done on 26,000 volunteers …, The Phase 3 human clinical trials of India’s first indigenous Covid vaccine Covaxin began in mid-November, targeted to be done on 26,000 volunteers …, Read More